Skip to main content.

Friday, November 23, 2007

Some recent news (from Mind Hacks) on the ethics of cognitive enhancement. An important observation comes in the last paragraph: we should be going more to improve nutrition and lifestyle as already-existing neuroenhancers. If we can't make these factors more readily available to the poor and disadvantaged, it's hard to see how Big Pharma will provide something better.
The British Medical Association has just released a report on the ethics of using medical technology to increase cognitive function and optimise the brain. Although the report looks to possible futures, many of them are already upon us.

The report is an interesting sign that cognitive enhancement, using largely physical interventions such as drugs and implants, is now a topic important enough to trouble the UK's professional medical association.

Many of the ethical concerns centre around a potential future where brain enhancing interventions are largely available to the wealthy, leading to a 'brain gap' where the less well off will have relatively poorer mental functioning because they can't access the same cognitive benefits.

However, this is exactly the situation we already have.

Thursday, November 22, 2007

My Neuroethics students are preparing their final projects--presentations begin Monday. I'm expecting some good papers and some very creative projects. The following would certainly earn an "A" for creativity.


Wednesday, May 16, 2007

An interesting article in the WSJ last week about recent neuroscientific research on moral intuitions and judgments.
Most of us feel a rush of righteous certainty in the face of a moral challenge, an intuitive sense of right or wrong hard to ignore yet difficult to articulate.

A provocative medical experiment conducted recently by neuroscientists at Harvard, Caltech and the University of Southern California strongly suggests these impulsive convictions come not from conscious principles but from the brain trying to make its emotional judgment felt.
Science Journal - WSJ.com